Patients' Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study

被引:0
作者
Nehlin, Christina [1 ,2 ]
Backstrom, Josefin [1 ,2 ]
Brander, Charlotte Wollert [1 ,2 ]
Oster, Caisa [1 ,2 ]
机构
[1] Uppsala Univ, Dept Med Sci, Psychiat, UAS Entrance 10, SE-75185 Uppsala, Sweden
[2] Uppsala Univ Hosp, Div Psychiat, Uppsala, Sweden
关键词
Opioid agonist treatment; medication for opioid use disorder; patients' perspective; qualitative; treatment length; coming off treatment; thematic analysis;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims:Opioid agonist treatment (OAT) programs are life-saving, as they reduce opioid use, overdoses, and criminal activities. Disadvantages reported with long-term OAT include side effects of the medication, especially on cognitive ability and sexual function, which may discourage potential participants. Many of those who participate in OAT have a desire to come off treatment. The aims of this study were to explore patients' thoughts about coming off OAT and to investigate their perceptions of what support they would need in order to realize a planned withdrawal from OAT. Methods:A qualitative interview study with semi-structured interviews, using applied thematic analysis. Persons with experiences of participating in OAT were invited from Swedish programs and a private Facebook community. Results:Fifteen persons, with a mean of 9.6 (+/- 6.4) years of treatment experience, were included. The participants underlined the need for a patient-centered focus within the treatment. They wanted to be regarded as capable of deciding if, when, and how a planned ending was to take place. They also called for staff to be supportive in making such decisions. Participants recommended staff to be sensitive to the needs of the specific patient and to have strategies for coming off OAT that could be adjusted for the single person. Conclusions:OAT programs need to be continually updated and adapted to the persons who can benefit from them. Applying a person-centered, holistic perspective would enhance the quality of the treatment by emanating from individual goals. Regulatory guidelines need to take into account research on patient experiences and perspectives on coming off.
引用
收藏
页数:7
相关论文
共 51 条
[1]  
[Anonymous], EUR DRUG REP
[2]  
[Anonymous], 2019, WORLD DRUG REPORT 20
[3]  
[Anonymous], 2016, 20161 HSLFFS NAT BO
[4]  
[Anonymous], 2020, LAKEMEDELSASSISTERAD
[5]  
[Anonymous], OPIOID DRUGS MAINTEN
[6]   Learning from Gothenburg model of person centred healthcare [J].
Britten, Nicky ;
Ekman, Inger ;
Naldemirci, Oncel ;
Javinger, Mikaela ;
Hedman, Hakan ;
Wolf, Axel .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
[7]   A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder [J].
Cioe, Katharine ;
Biondi, Breanne E. ;
Easly, Rebecca ;
Simard, Amanda ;
Zheng, Xiao ;
Springer, Sandra A. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 119
[8]   A good quality of life under the influence of methadone: A qualitative study among opiate-dependent individuals [J].
De Maeyer, Jessica ;
Vanderplasschen, Wouter ;
Camfield, Laura ;
Vanheule, Stijn ;
Sabbe, Bernard ;
Broekaert, Eric .
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2011, 48 (10) :1244-1257
[9]   The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study [J].
Degenhardt, Louisa ;
Charlson, Fiona ;
Mathers, Bradley ;
Hall, Wayne D. ;
Flaxman, Abraham D. ;
Johns, Nicole ;
Vos, Theo .
ADDICTION, 2014, 109 (08) :1320-1333
[10]   A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder [J].
Dennis, Brittany B. ;
Sanger, Nitika ;
Bawor, Monica ;
Naji, Leen ;
Plater, Carolyn ;
Worster, Andrew ;
Woo, Julia ;
Bhalerao, Anuja ;
Baptist-Mohseni, Natasha ;
Hillmer, Alannah ;
Rice, Danielle ;
Corace, Kim ;
Hutton, Brian ;
Tugwell, Peter ;
Thabane, Lehana ;
Samaan, Zainab .
TRIALS, 2020, 21 (01)